The Food and Drug Administration (FDA) has approved Zegalogue® (dasiglucagon) for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes aged...
Coherent market insights has published the addition of a new Market Intelligence report, entitled Infant nutrition market. The report contains an elaboration...